Innovative Research Award

Jaafar Hadi
The University of Texas MD Anderson Cancer Center

Jaafar Hadi
Affiliation The University of Texas MD Anderson Cancer Center
Country United States
Scopus ID 59131794500
Documents 5
Citations 12
h-index 2
Subject Area Health
Event Petroleum Engineering Awards
ORCID 0009-0000-0585-6842

Jaafar Hadi is a researcher affiliated with The University of Texas MD Anderson Cancer Center whose recent scholarly work addresses cancer biology, tumor immunology, clinical behavior, and mechanisms associated with treatment response. His recent publications examine myeloid-mediated immunoregulation across squamous cell carcinomas and clinical patterns associated with recurrence in oral tongue squamous cell carcinoma. These studies provide a research profile centered on understanding tumor–immune interactions and factors that may influence therapeutic resistance and disease outcomes. [1] [2]

Abstract

The research profile of Jaafar Hadi is represented by recent scholarly contributions concerning squamous cell carcinomas, tumor immunoregulation, recurrence, and resistance to immune checkpoint inhibitor therapy. A 2026 article in Cancers investigates myeloid-mediated immunoregulation and resistance to immune checkpoint inhibitor therapy across squamous cell carcinomas, with emphasis on mechanisms and potential reprogramming strategies. [1] A second 2026 article in Laryngoscope Investigative Otolaryngology examines smoking status and recurrence in oral tongue squamous cell carcinoma, contributing evidence concerning convergent clinical behavior. [2] Together with a related working paper on myeloid-mediated immunoregulation, these publications indicate a research direction focused on tumor–immune interactions and clinically relevant mechanisms of cancer progression and treatment response. [3]

Keywords

Squamous cell carcinoma; tumor immunology; myeloid cells; immunoregulation; immune checkpoint inhibitors; treatment resistance; oral tongue cancer; cancer recurrence; tumor microenvironment; translational oncology.

Introduction

Squamous cell carcinomas comprise a diverse group of malignancies in which interactions between tumor cells, immune populations, and the surrounding microenvironment can influence disease behavior and therapeutic response. Contemporary cancer research increasingly examines the biological mechanisms that allow tumors to evade immune surveillance and develop resistance to immune-based therapies. The supplied publication record places Jaafar Hadi’s recent work within this broader area, particularly through investigation of myeloid-mediated immunoregulation and clinical recurrence patterns. [1] [2]

Research Profile

The available research record identifies Health as the subject area associated with Jaafar Hadi. The supplied bibliometric information lists five documents, 12 citations, and an h-index of 2. These metrics provide a quantitative snapshot of the indexed research record and should be interpreted in relation to publication age, disciplinary citation practices, collaboration patterns, and the evolving nature of the research portfolio.[1] [2]

Research Contributions

Based on the supplied publications, the principal areas of contribution can be summarized as follows:

  • Investigation of myeloid-mediated immunoregulation across squamous cell carcinomas and its relationship to the tumor immune environment. [1]
  • Analysis of mechanisms associated with resistance to immune checkpoint inhibitor therapy, including consideration of potential reprogramming strategies. [1]
  • Clinical investigation of smoking status and recurrence in oral tongue squamous cell carcinoma, with emphasis on convergent clinical behavior. [2]
  • Development of a research direction linking tumor immunoregulation, therapeutic resistance, recurrence, and translational oncology. [1] [2] [3]

Publications

The following publications and working paper were supplied as part of the research record:

  1. Hadi, Jaafar A.; Nizami, Zohra N.; Noor, Ahmed Tajmim; Osman, Abdullah A.; Myers, Jeffrey N. “Myeloid-Mediated Immunoregulation and Resistance to Immune Checkpoint Inhibitor Therapy Across Squamous Cell Carcinomas: Mechanisms and Reprogramming Strategies.” Cancers, 2026-08-22.
  2. Hadi, Jaafar A.; Li, Guojun; Nizami, Zohra N.; Wang, Jennifer; Reeves, Bridget; Veeramachaneni, Ratna; Roberts, Dianna; Gomez, Lorena Isabel; Kadara, Humam; Mansour, Mena et al. “Smoking Status and Recurrence in Oral Tongue Squamous Cell Carcinoma: Evidence for Convergent Clinical Behavior.” Laryngoscope Investigative Otolaryngology, 2026-06.
  3. Hadi, Jaafar A. et al. “Myeloid-Mediated Immunoregulation Across Squamous Cell Carcinomas.” Working paper.

Research Impact

The available bibliometric record lists five documents, 12 citations, and an h-index of 2 for the supplied Scopus author profile. These indicators suggest an emerging indexed research record rather than a mature, long-established bibliometric portfolio. The recent dates of the supplied publications are also relevant when interpreting citation counts because newly published research generally has less time to accumulate citations.[1] [2]

Award Suitability

The supplied record provides a scholarly basis for consideration under an Innovative Research Award framework, particularly where recognition is intended to acknowledge emerging research addressing important scientific or clinical questions. Hadi’s recent work demonstrates engagement with contemporary questions in cancer immunology and oncology, including immune-mediated regulation, resistance to immune checkpoint inhibitor therapy, and recurrence in squamous cell carcinoma. [1] [2]

Conclusion

Jaafar Hadi’s supplied research record reflects an emerging scholarly focus on cancer immunology, squamous cell carcinomas, tumor–immune interactions, treatment resistance, and recurrence. His 2026 publications address myeloid-mediated immunoregulation and resistance to immune checkpoint inhibitor therapy as well as clinical recurrence in oral tongue squamous cell carcinoma. [1] [2] The associated working paper further indicates continuity in the investigation of myeloid-mediated immunoregulation. [3]

References

  1. Hadi, Jaafar A.; Nizami, Zohra N.; Noor, Ahmed Tajmim; Osman, Abdullah A.; Myers, Jeffrey N. (2026). Myeloid-Mediated Immunoregulation and Resistance to Immune Checkpoint Inhibitor Therapy Across Squamous Cell Carcinomas: Mechanisms and Reprogramming Strategies. Cancers.
    DOI: https://doi.org/10.3390/cancers18172724
  2. Hadi, Jaafar A.; Li, Guojun; Nizami, Zohra N.; Wang, Jennifer; Reeves, Bridget; Veeramachaneni, Ratna; Roberts, Dianna; Gomez, Lorena Isabel; Kadara, Humam; Mansour, Mena et al. (2026). Smoking Status and Recurrence in Oral Tongue Squamous Cell Carcinoma: Evidence for Convergent Clinical Behavior. Laryngoscope Investigative Otolaryngology.
    DOI: https://doi.org/10.1002/lio2.70477
  3. Hadi, Jaafar A. et al. (2026). Myeloid-Mediated Immunoregulation Across Squamous Cell Carcinomas. Working paper, Multidisciplinary Digital Publishing Institute.
    DOI: https://doi.org/10.20944/preprints202607.1129.v1
  4. Elsevier. (n.d.). Scopus author details: Jaafar Hadi, Author ID 59131794500. Scopus.
    https://www.scopus.com/pages/authors/59131794500
Jaafar Hadi | Health | Innovative Research Award

You May Also Like